Company Monitoring Page for Novo-Nordisk

latest headlines for company on cafepharma

Denmark to restrict Ozempic, other GLP-1 drugs, to treat type 2 diabetes
Reuters
Wed, 05/1/24 - 09:33 am
Tags:
Denmark, type 2 diabetes, GLP-1 agonists, Novo Nordisk, Ozempic
How expanded use of GLP-1s could affect long-term outlooks for Eli Lilly and Novo Nordisk
Yahoo Finance
Tue, 04/30/24 - 08:56 am
Tags:
Novo Nordisk, Eli Lilly, earnings, obesity, weight loss, GLP-1 agonist, Ozempic, Wegovy, Zepbound, Mounjaro
One dose of Novo Nordisk's Wegovy back in supply, FDA website shows
Reuters
Mon, 04/29/24 - 10:54 pm
Tags:
Novo Nordisk, Wegovy, drug shortages
FDA calls for adcomm to discuss Novo Nordisk's filing for weekly insulin
Fierce Pharma
Mon, 04/29/24 - 11:22 am
Tags:
Novo Nordisk, Awiqli, weekly insulin, FDA, diabetes, insulin icodec, insulin
Why the obesity drug market is about to get a lot more crowded
Medical Marketing and Media
Fri, 04/26/24 - 11:49 am
Tags:
obesity, Novo Nordisk, Wegovy, Eli Lilly, Zepbound, Roche, AstraZeneca
US Senate committee investigates pricing of Novo's Ozempic and Wegovy
Reuters
Wed, 04/24/24 - 09:16 pm
Tags:
Senate, Bernie Sanders, drug pricing, Novo Nordisk, Ozempic, Wegovy
About 3.6 mln Medicare beneficiaries could be eligible for Wegovy coverage, study shows
Reuters
Wed, 04/24/24 - 09:59 am
Tags:
Novo Nordisk, Wegovy, weight loss, Medicare
Big Pharma market caps surge to start 2024 despite economic headwinds
Medical Marketing and Media
Tue, 04/23/24 - 10:38 am
Tags:
Big Pharma, market cap, Novo Nordisk, Eli Lilly
Ozempic's latest reported side effect: pregnancy
Axios
Fri, 04/19/24 - 11:23 am
Tags:
Novo Nordisk, Ozempic, Wegovey, diabetes, PCOS, Fertility
Drugs Like Ozempic And Mounjaro Could Treat Other Conditions—Here’s What Scientists Are Looking At
Forbes
Thu, 04/18/24 - 10:25 pm
Tags:
Novo Nordisk, Eli Lilly, Ozempic, Wegovy, Zepbound, Mounjaro, anxiety, addiction, heart disease, liver disease
Lawmakers probe Novo Nordisk over drug's discontinuation
Beckers Hospital Review
Wed, 04/17/24 - 10:01 pm
Tags:
Novo Nordisk, Levemir, Senate, insulin, diabetes
3 patent expirations in 2024 and how companies are pivoting
Pharma Voice
Wed, 04/17/24 - 11:13 am
Tags:
patents, patent cliff, Bayer, J&J, Xarelto, Novo Nordisk, Victoza, Otsuka, Lundbeck, Abilify
4 Investigational Weight Loss Drugs That Could Change the Market
BioSpace
Mon, 04/15/24 - 11:09 am
Tags:
weight loss, Novo Nordisk, CagriSema, Eli Lilly, orforglipro, Viking Therapeutics, VK-2735, Inversago Pharma, INV-202
European regulators find no evidence of link between new obesity medicines and suicidal thoughts
Stat
Fri, 04/12/24 - 11:09 am
Tags:
Novo Nordisk, Ozempic, Wegovy, EMA, obesity, weight loss, suicide
GLP-1s Like Novo Nordisk’s Ozempic Do Not Increase Thyroid Cancer Risk: Study
BioSpace
Wed, 04/10/24 - 09:48 am
Tags:
Novo Nordisk, Ozempic, Victoza, GLP-1 agonist, thyroid cancer
EMA to Review Diabetes and Weight-Loss Drugs for Suicidal Ideation Risk
BioSpace
Tue, 04/9/24 - 11:11 am
Tags:
EMA, Europe, diabetes, weight loss, Novo Nordisk, Ozempic, Wegovy, Eli Lilly, Trulicity, Saxenda, Rybelsus, Victoza
Brand managers reflect on historic launch of Wegovy
Medical Marketing and Media
Mon, 04/8/24 - 12:01 pm
Tags:
Novo Nordisk, Wegovy, obesity, drug launches, brand management
FTC Will Have More Time to Review Novo’s $16.5B Catalent Buy
BioSpace
Fri, 04/5/24 - 11:52 am
Tags:
Novo Nordisk, M&A, Catalent, SEC
Novo Nordisk pushes back after price gouging accusations by Bernie Sanders
Biopharma Reporter
Thu, 04/4/24 - 10:55 am
Tags:
Novo Nordisk, Wegovy, Ozempic, Bernie Sanders, drug pricing
Drugmaker seeks approval for China's first biosimilar Ozempic
Reuters
Wed, 04/3/24 - 11:07 am
Tags:
Novo Nordisk, Ozempic, China, biosimilars, Hangzhou Jiuyuan Gene Engineering

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.